Skip to main content Skip to footer
IPM Alliance
Menu
  • Disease areas
    • Cardiology
    • Eye Disease
    • Neurology
    • Infectious disease
    • Cardiometabolic
    • Oncology
  • Latest News
  • Playbook
  • AI & Tech
  • Activities
  • About
    • Governance
Subscribe

Neurology

Neurology
8 June 2026 | 3 mins read

Huntington’s Disease Gets an Oral Target-Engagement Signal

Skyhawk’s SKY-0515 interim data show strong mutant huntingtin lowering, putting Huntington’s disease back at the centre of the precision neurology debate.

Neurology
23 May 2026 | 3 mins read

Parkinson’s Research Moves From Tracking Progression to Defining Biology

Neurology
23 May 2026 | 2 mins read

MS Monitoring Starts Moving Beyond the MRI Bottleneck

Neurology
23 May 2026 | 2 mins read

Latin America Challenges the Dementia Biomarker Evidence Gap

Neurology
23 May 2026 | 3 mins read

China’s Alzheimer’s Blood-Test Rollout Turns Diagnosis Into an Access Market

Neurology
23 May 2026 | 2 mins read

Alzheimer’s Blood Testing Moves Toward Routine Care

Neurology
23 May 2026 | 3 mins read

Alzheimer’s Drugs Force NICE Back Into the Value Debate

Neurology
23 May 2026 | 3 mins read

Europe Starts Treating Brain Health as System Resilience

  • ←
  • 1
  • 2
  • 3

Free IPM Alliance Newsletter

Insights on science, policy and access in personalised medicine.

Sign up for free

Subscribe to Our Newsletter

Google reCaptcha: Invalid site key.

By subscribing, you agree to receive updates from IPM Alliance. You can unsubscribe at any time. For more information, please see our Privacy Policy.

Closing the last mile of personalised medicine implementation.

Disease areas
OncologyCardiometabolicCardiologyNeurologyEye DiseasesInfectious Diseases
Latest news
AI & TechAlertsSignals
Activities
EventsEducational Courses
Other
AboutPlaybookPollsPrivacy policyCookie policy
©2026 All rights reserved